卡介苗膀胱内灌注治疗对肾移植受者浅表性膀胱癌的安全性和有效性。 - Suppr | 超能文献

The safety and efficacy of Bacillus Calmette-Guerin intravesical therapy in kidney transplant recipients with superficial bladder cancer.

作者信息

Alkassis Marwan, Abi Tayeh Georges, Khalil Nour, Mansour Raymond, Lilly Eddy, Sarkis Julien, Moukarzel Maroun

机构信息

Department of Urology, Hotel Dieu de France Hospital, University of Saint Joseph, Beirut, Lebanon.

出版信息

Clin Transplant. 2021 Jul;35(7):e14377. doi: 10.1111/ctr.14377. Epub 2021 Jun 13.

DOI:10.1111/ctr.14377

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

The safety and efficacy of Bacillus Calmette-Guerin intravesical therapy in kidney transplant recipients with superficial bladder cancer.卡介苗膀胱内灌注治疗对肾移植受者浅表性膀胱癌的安全性和有效性。

Clin Transplant. 2021 Jul;35(7):e14377. doi: 10.1111/ctr.14377. Epub 2021 Jun 13.

2

Intravesical bacillus Calmette-Guèrin for the treatment of superficial bladder cancer in renal transplant patients.膀胱内灌注卡介苗治疗肾移植患者的浅表性膀胱癌

Transplantation. 2003 Nov 27;76(10):1514-6. doi: 10.1097/01.TP.0000090748.32764.0F.

3

Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.经尿道治疗非肌肉浸润性膀胱癌：系统评价和荟萃分析。

J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.

4

Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review.卡介苗膀胱内灌注治疗非肌层浸润性膀胱癌：综述

Int J Urol. 2018 Jan;25(1):18-24. doi: 10.1111/iju.13410. Epub 2017 Jul 25.

5

Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.卡介苗膀胱内灌注治疗浅表性膀胱癌：卡介苗活性对治疗结果的影响

J Urol. 1985 Jul;134(1):48-53. doi: 10.1016/s0022-5347(17)46976-x.

6

Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.纤维蛋白凝块抑制剂对卡介苗膀胱灌注治疗浅表性膀胱肿瘤的不良影响。

J Urol. 1990 Dec;144(6):1362-4. doi: 10.1016/s0022-5347(17)39741-0.

7

Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.浅表性膀胱癌中膀胱内灌注卡介苗与经皮注射卡介苗对比膀胱内灌注卡介苗的前瞻性随机对照研究

J Urol. 1991 Apr;145(4):738-40. doi: 10.1016/s0022-5347(17)38439-2.

8

Should intravesical Bacillus Calmette-Guérin be employed in transplant recipients with bladder carcinoma?卡介苗膀胱灌注是否应用于膀胱癌移植受者？

Transpl Infect Dis. 2010 Aug 1;12(4):358-62. doi: 10.1111/j.1399-3062.2010.00506.x. Epub 2010 Apr 19.

9

Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.接受1个或2个为期6周的膀胱内卡介苗治疗的患者的长期随访：无肿瘤反应的可能预测因素分析。

J Urol. 1990 Sep;144(3):652-7. doi: 10.1016/s0022-5347(17)39546-0.

10

Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.卡介苗与多柔比星与噻替派：202例浅表性膀胱癌患者的随机前瞻性研究

J Urol. 1990 Mar;143(3):502-6. doi: 10.1016/s0022-5347(17)40002-4.

引用本文的文献

1

Urothelial Carcinoma Arising on a Functional Kidney Graft.功能性肾移植上发生的尿路上皮癌

Biomedicines. 2025 May 6;13(5):1118. doi: 10.3390/biomedicines13051118.

2

Clinical characteristics and treatment outcomes of kidney transplant recipients with de novo urothelial carcinoma: thirty years of experience from a single center.肾移植受者新发尿路上皮癌的临床特征和治疗结局：单中心 30 年经验。

BMC Urol. 2023 Apr 28;23(1):71. doi: 10.1186/s12894-023-01232-7.